Skip to content

Lifecore Biomedical, Inc. LFCR All other states — Tax credit carryforward amount

Similar metrics at other companies

Novanta logo
NOVTUS State Credits — Tax Credit Carryforward Amount
$2.7M+3.8%
Liberty Latin America logo
LILAUnited States — Tax credit carryforwards
$21M+110%
Kulicke & Soffa Industries logo
KLICTax credit carryforwards
$6.38M+15.2%
Novanta logo
NOVTUS — Tax Credit Carryforward Amount
$1.5M
1st Source Corporation logo
SRCETax credit carryover
$2.55M
Maze Therapeutics, Inc. Common Stock logo
MAZECA — Tax Credit Carryforward Amount
$10.87M

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-37.3%
Enterprise value$333.06M+6.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TaxCreditCarryforwardAmount.

The official record: Lifecore Biomedical, Inc.’s 10-K, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s all other states — tax credit carryforward amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s all other states — tax credit carryforward amount?
Lifecore Biomedical, Inc. (LFCR) reported all other states — tax credit carryforward amount of $2.02M in Q1 2025.
What does all other states — tax credit carryforward amount mean?
This metric quantifies the total value of unused tax credits generated in specific geographic jurisdictions outside of the company's primary operating regions that are available to reduce future state income tax obligations. These credits represent direct reductions to tax liability rather than deductions from taxable income, providing a tangible benefit to future net income. Tracking this balance helps investors understand the company's potential for future tax savings and the efficiency of its tax planning strategies across various state jurisdictions.